Ibrutinib and Lenalidomide in Treating Patients With Myelodysplastic Syndrome

Clinical trial NCT03359460 · COMPLETED

Trial details

NCT number: NCT03359460
Sponsor: University of California, Davis
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Myelodysplastic Syndrome Previously Treated Myelodysplastic Syndrome Refractory High Risk Myelodysplastic Syndrome Secondary Myelodysplastic Syndrome Therapy-Related Myelodysplastic Syndrome

Start date: 2017-12-01
Primary completion: 2019-08-29
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.